title: Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population.
abstract: Reductions in glutamate function are regarded as an important contributory factor in schizophrenia. However, there is a paucity of animal models characterized by developmental and sustained reductions in glutamate function. Pharmacological models using NMDA antagonists have been widely used but these typically produce only transient changes in behavior and brain function. Likewise, mice with homozygous constitutive reductions in glutamate receptor expression show stable brain and behavioral changes, but many of these phenotypes are more severe than the human disease. The current study examines a variety of schizophrenia-related EEG measures in mice with a heterozygous alteration of the NMDA receptor NR1 subunit gene (NR1) that is known to result in reduced NR1 receptor expression in the homozygous mouse (NR1-/-). (NR1+/-) mice showed a 30% reduction in NR1 receptor expression and were reared after weaning in either group or isolated conditions. Outcome measures include the response to paired white noise stimuli, escalating inter-stimulus intervals (ISIs) and deviance-related mismatch negativity (MMN). In contrast to what has been reported in (NR1-/-) mice and mice treated with NMDA antagonists, (NR1+/-) mice showed no change on obligatory Event Related Potential (ERP) measures including the murine P50 and N100 equivalents (P20 and N40), or measures of baseline or evoked gamma power. Alternatively, (NR1+/-) mice showed a marked reduction in response to a deviant auditory tone during MMN task. Data suggest that EEG response to deviant, rather than static, stimuli may be more sensitive for detecting subtle changes in glutamate function. Deficits in these heterozygous NR1 knockdown mice are consistent with data demonstrating MMN deficits among family members of schizophrenia patients and among prodromal patients. Therefore, the current study suggests that (NR1+/-) mice may be among the most sensitive models for increased vulnerability to schizophrenia.
authors.affiliation: Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Featherstone
authors.affiliation: Translational Psychiatry, CNS - Astellas Research Institute of America LLC, Skokie, IL, USA.
authors.forename: Rick
authors.initials: R
authors.lastname: Shin
authors.affiliation: Translational Psychiatry, CNS - Astellas Research Institute of America LLC, Skokie, IL, USA.
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Kogan
authors.affiliation: Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Yuling
authors.initials: Y
authors.lastname: Liang
authors.affiliation: Translational Psychiatry, CNS - Astellas Research Institute of America LLC, Skokie, IL, USA.
authors.forename: Mitsuyuki
authors.initials: M
authors.lastname: Matsumoto
authors.affiliation: Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: siegels@upenn.edu.
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Siegel
mesh_terms: D000818:Animals; D001921:Brain / Q000503:physiopathology*; D004195:Disease Models, Animal; D005071:Evoked Potentials / Q000502:physiology*; D065818:Gamma Rhythm / Q000502:physiology*; D020022:Genetic Predisposition to Disease; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D062706:Prodromal Symptoms; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D012559:Schizophrenia / Q000503:physiopathology*; D012934:Social Isolation
chemical_list: C409466:NR1 NMDA receptor; D016194:Receptors, N-Methyl-D-Aspartate
keywords: EEG; Mismatch negativity; Mouse; NMDA; Schizophrenia